RNeasy Mini Kit

High-quality total RNA in minutes.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

QIAGEN Deep Dive – QIAcuity digital PCR

Home  >  Investor Relations  >  Events & Presentations  >  QIAGEN Deep Dive – QIAcuity digital PCR

QIAGEN Deep Dive – QIAcuity digital PCR

We are pleased to invite you to the next episode in a series of QIAGEN Deep Dives. This virtual event will focus on QIAcuity, our digital PCR solution.

The session will provide insights into how QIAGEN is driving adoption of QIAcuity digital PCR, expanding into new application areas and building its position. You will hear directly from customers and QIAGEN experts and have the opportunity to engage in a live Q&A session.

Speaker bios

Download all

See how researchers are applying QIAcuity digital PCR to address complex scientific challenges

Identifying the genetics behind obesity using dPCR

Obesity is one of the world’s most complex chronic diseases, with genetics playing a critical role in determining individual risk. Dr. Johanna Andersson-Assarsson’s research highlights how QIAcuity digital PCR enables precise copy number analysis, helping uncover genetic factors that could advance future obesity therapies and research.

  Learn More  

A new climate for vector-borne diseases

As climate change reshapes the spread of vector-borne diseases, researchers are turning to digital PCR to better understand emerging health risks. Dr. Melissa Nolan’s work highlights how QIAcuity digital PCR supports sensitive detection and helps advance public health research in a changing world.

  Learn More  

A life after the first successful pediatric CAR T-cell Therapy

After becoming the first child successfully treated with CAR-T cell therapy, Emily Whitehead’s journey became a milestone in cancer research. Her story showcases how advances in cell and gene therapy are helping transform scientific discovery into real-world patient benefit.

  Learn More